Hopp til innhold
NHI.no
Annonse

Trokanter major smertesyndrom: Prognose

Innhold i artikkelen

Tilstanden er godartet, men har et langvarig forløp. Den varer vanligvis i flere måneder. Cirka to av tre pasienter med trokanter major smertesyndrom som ikke har annen sykdom i hofteområdet blir smertefrie og gjenvinner normal funksjon innen ett år. Men rundt en tredjedel av pasientene vil fortsatt ha symptomer etter ett år, og hos tre av sju pasienter kan plagene vedvare i mange år. Sjansene for å bli helt kvitt plagene er størst dersom det ikke foreligger medvirkende årsaker som langtkommen hofteleddsartrose eller langvarige ryggplager.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Trokanter major smertesyndrom . Referanselisten for dette dokumentet vises nedenfor

  1. Juel NG. Laterale hoftesmerter. Fysikalsk medisin og rehabilitering - veileder. Sist faglig oppdatert 03.06.2024. Siden lest 24.08.2025. www.helsebiblioteket.no
  2. Barratt PA, Brookes N, Newson A. Conservative treatments for greater trochanteric pain syndrome: a systematic review. Br J Sports Med. 2017 Jan;51(2):97-104. Epub 2016 Nov 10. PMID: 27834675 PubMed
  3. Kane SF, Olewinski LH, Tamminga KS. Management of chronic tendon injuries. Am Fam Physician. 2019 Aug 1;100(3):147-157. PubMed
  4. Pianka MA, Serino J, DeFroda SF, Bodendorfer BM. Greater trochanteric pain syndrome: Evaluation and management of a wide spectrum of pathology. SAGE Open Med. 2021 Jun 3;9:20503121211022582. doi: 10.1177/20503121211022582. PMID: 34158938 PubMed
  5. Chi AS, Long SS, Zoga AC, et al. Prevalence and pattern of gluteus medius and minimus tendon pathology and muscle atrophy in older individuals using MRI. Skeletal Radiol 2015; 44:1727. PubMed
  6. Ganderton C, Semciw A, Cook J, et al. Gluteal Loading Versus Sham Exercises to Improve Pain and Dysfunction in Postmenopausal Women with Greater Trochanteric Pain Syndrome: A Randomized Controlled Trial. J Womens Health (Larchmt) 2018; 27:815. PubMed
  7. Brinks A, van Rijn RM, Willemsen SP, Bohnen AM, Verhaar JA, Koes BW, et al. Corticosteroid injections for greater trochanteric pain syndrome: a randomized controlled trial in primary care. Ann Fam Med. 2011 May-Jun. 9(3):226-34. PMID: 21555750 PubMed
  8. McEvoy JR, Lee KS, Blankenbaker DG, et al. Ultrasound-guided corticosteroid injections for treatment of greater trochanteric pain syndrome: Greater trochanter bursa versus subgluteus medius bursa. Am J Roentgenol 2013; 201: W313. pmid:23883246 PubMed
  9. Cohen SP, Strassels SA, Foster L, et al. Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomised controlled trial. BMJ 2009; 338: b1088. BMJ (DOI)
  10. Mellor R, Bennell K, Grimaldi A, et al. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial. BMJ 2018; 361:k1662. BMJ (DOI)
  11. Mani-Babu S, Morrissey D, Waugh C, et al. The effectiveness of extracorporal shock wave therapy in lower limb tendinopathy. Am J Sports Med 2015; 43(3): 752-61. PubMed
  12. Lustenberger DP, Ng VY, Best TM, Ellis TJ. Efficacy of treatment of trochanteric bursitis: a systematic review. Clin J Sport Med 2011; 21:447. PubMed
  13. Ramon S, Russo S, Santoboni F, et al. Focused Shockwave Treatment for Greater Trochanteric Pain Syndrome: A Multicenter, Randomized, Controlled Clinical Trial. J Bone Joint Surg Am. 2020; 102:1305-11. PMID: 32769596 PubMed
  14. Lievense A, Bierma-Zeinstra S, Schouten B, et al. Prognosis of trochanteric pain in primary care. Br J Gen Pract 2005; 55(512): 199-204. www.ncbi.nlm.nih.gov
  15. Reid D. The management of greater trochanteric pain syndrome: a systematic literature review. J Orthop. 2016;13(1):15–28. www.ncbi.nlm.nih.gov
Annonse
Annonse